The global cell sorting market is expected to grow at a CAGR of 7.0% between 2016 and 2021. Growth in this market is primarily driven by factors such as technological advancements in cell sorters, rising funding and investments for development of innovative cell sorting techniques, and growing adoption of cell sorting in research activities. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, the high cost of instruments, reluctance among researchers to use cell sorters in emerging countries, and lack of awareness and technical knowledge regarding the use of cell sorters are the key factors limiting the growth of this market.
The major players in the global cell sorting market include Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sony Biotechnology Inc. (U.S.), Miltenyi Biotec GmbH (Germany), Affymetrix Inc. (U.S.), Sysmex Partec GmbH (Japan), On-Chip Biotechnologies Co., Ltd. (Japan), Cytonome/ST, LLC (U.S.), and Union Biometrica, Inc. (U.S.). Analysis of the market developments between 2013 and 2016 reveals that new product launches and agreements & collaborations are the most widely adopted growth strategy by players in the global cell sorting market. Players adopted this strategy to strengthen their product portfolios, expand their geographic reach, and maintain a competitive position in the market. In May 2016, Becton, Dickinson and Company (U.S.) introduced BD FACSMelody System, a benchtop flow cytometry cell sorter which is easy-to-learn, install, and use. Furthermore, in April 2015, Bio-Rad Laboratories, Inc. (U.S.) launched the easy-to-use benchtop S3e Cell Sorter (488/640 nm) featuring the fluorescence wavelengths commonly used by immunologists.
Key players also adopted agreements and collaborations as their growth strategy to expand their product portfolios, extend their geographic presence, and gain access to novel technologies. For instance, in June 2016, Cytonome (U.S.) entered into an agreement with Thermo Fisher Scientific (U.S.) to co-develop and distribute a new line of flow cytometry cell sorting technology. This agreement combined Thermo Fisher’s extensive channel reach capabilities and Cytonome’s sorting technology expertise to develop innovative technologies and strengthen its geographic reach. Likewise, in February 2015, Becton, Dickinson and Company (U.S.) collaborated with Cellular Research, Inc. (U.S.) to jointly promote BD’s powerful BD FACS single-cell sorting instrumentation and software with Cellular Research’s Precise assays based on the Molecular Indexing technology.
Other strategies adopted by market players include acquisitions and geographic expansions to enter new markets and strengthen their positions. For instance, in August 2014, Beckman Coulter acquired Xitogen Technologies, Inc. (China). The acquisition of the Xitogen business includes fully staffed facilities in Suzhou and Dalian, which will function as research & development and manufacturing centers for Beckman Coulter. This acquisition helped the company expand and strengthen its presence in the Chinese market.
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Email: [email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE